Catalyst Wire Dossier Catalyst Wire Dossier

Dentoxol

· Ingalfarma SpA
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Dentoxol, covering 2018-12-21 to 2022-04-14. Get the full timeline:

Most recent: Clinical Trial Update: Dose-ranging Study of Dentoxol® Mouthrinse for Managing Oral Symptoms in People With Epidermolysis Bullosa. [Phase 2]

See pricing